PMID- 4042896
OWN - NLM
STAT- MEDLINE
DCOM- 19851121
LR  - 20131121
IS  - 0012-0472 (Print)
IS  - 0012-0472 (Linking)
VI  - 110
IP  - 43
DP  - 1985 Oct 25
TI  - [Hypersensitivity phenomena in dialysis patients. Incidence of eosinophilia, 
      raised IgE and ethyleneoxide-induced antibodies].
PG  - 1641-5
AB  - The hypersensitivity parameters eosinophil count, serum IgE and IgE-type 
      antibodies to ethylene oxide-albumin conjugates (ETO-antibodies), were determined 
      in 182 dialysis patients. Eosinophilia was seen in 21.7% of patients, IgE 
      elevation in 21.4% and ETO-antibodies in 12.4%. A pathological change in at least 
      one of the measured parameters was present in 33.1%. The appearance of 
      ETO-antibodies was frequently associated with severe clinical symptoms, 
      especially asthma and anaphylactic shock. Sensitisation is apparently common in 
      dialysis patients. Since ETO-antibodies are often associated with severe clinical 
      symptoms, their presence should be sought in those dialysis patients showing 
      incompatibility reactions or asthma.
FAU - Rumpf, K W
AU  - Rumpf KW
FAU - Seubert, S
AU  - Seubert S
FAU - Seubert, A
AU  - Seubert A
FAU - Lowitz, H D
AU  - Lowitz HD
FAU - Valentin, R
AU  - Valentin R
FAU - Rippe, H
AU  - Rippe H
FAU - Ippen, H
AU  - Ippen H
FAU - Scheler, F
AU  - Scheler F
LA  - ger
PT  - Case Reports
PT  - English Abstract
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
TT  - Hypersensitivitatsphanomene bei Dialysepatienten. Haufigkeit von Eosinophilie, 
      IgE-Erhohung und Ethylenoxid-induzierten Antikorpern.
PL  - Germany
TA  - Dtsch Med Wochenschr
JT  - Deutsche medizinische Wochenschrift (1946)
JID - 0006723
RN  - 0 (Antibodies)
RN  - 37341-29-0 (Immunoglobulin E)
RN  - JJH7GNN18P (Ethylene Oxide)
SB  - IM
MH  - Adult
MH  - Antibodies/*analysis
MH  - Asthma/etiology
MH  - Eosinophilia/*etiology
MH  - Ethylene Oxide/*immunology
MH  - Female
MH  - Humans
MH  - Immunoglobulin E/*analysis
MH  - Middle Aged
MH  - Renal Dialysis/*adverse effects
EDAT- 1985/10/25 00:00
MHDA- 1985/10/25 00:01
CRDT- 1985/10/25 00:00
PHST- 1985/10/25 00:00 [pubmed]
PHST- 1985/10/25 00:01 [medline]
PHST- 1985/10/25 00:00 [entrez]
AID - 10.1055/s-2008-1069061 [doi]
PST - ppublish
SO  - Dtsch Med Wochenschr. 1985 Oct 25;110(43):1641-5. doi: 10.1055/s-2008-1069061.